🚀 VC round data is live in beta, check it out!
Enhabit Valuation Multiples
Discover revenue and EBITDA valuation multiples for Enhabit and similar public comparables like Omada Health, Propel Funeral Partners, LNA Sante, Oncology Institute and more.
Enhabit Overview
About Enhabit
Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services for adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing a life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates a majority of its revenue from the Home Health segment.
Founded
2014
HQ
Employees
10.7K
Website
Sectors
Financials (LTM)
EV
$1B
Enhabit Financials
Enhabit reported last 12-month revenue of $1B and EBITDA of $109M.
In the same LTM period, Enhabit generated $526M in gross profit, $109M in EBITDA, and $6M in net income.
Revenue (LTM)
Enhabit P&L
In the most recent fiscal year, Enhabit reported revenue of $1B and EBITDA of $109M.
Enhabit expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $1B | XXX | $1B | XXX | XXX | XXX |
| Gross Profit | $526M | XXX | $520M | XXX | XXX | XXX |
| Gross Margin | 49% | XXX | 49% | XXX | XXX | XXX |
| EBITDA | $109M | XXX | $109M | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | 10% | XXX | XXX | XXX |
| EBIT Margin | 8% | XXX | 8% | XXX | XXX | XXX |
| Net Profit | $6M | XXX | ($5M) | XXX | XXX | XXX |
| Net Margin | 1% | XXX | (0%) | XXX | XXX | XXX |
| Net Debt | — | — | $405M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Enhabit Stock Performance
Enhabit has current market cap of $703M, and enterprise value of $1B.
Market Cap Evolution
Enhabit's stock price is $13.72.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $703M | -0.1% | XXX | XXX | XXX | $-0.09 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialEnhabit Valuation Multiples
Enhabit trades at 1.1x EV/Revenue multiple, and 10.7x EV/EBITDA.
EV / Revenue (LTM)
Enhabit Financial Valuation Multiples
As of April 18, 2026, Enhabit has market cap of $703M and EV of $1B.
Equity research analysts estimate Enhabit's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Enhabit has a P/E ratio of 113.3x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $703M | XXX | $703M | XXX | XXX | XXX |
| EV (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV/Revenue | 1.1x | XXX | 1.1x | XXX | XXX | XXX |
| EV/EBITDA | 10.7x | XXX | 10.7x | XXX | XXX | XXX |
| EV/EBIT | 13.7x | XXX | 13.3x | XXX | XXX | XXX |
| EV/Gross Profit | 2.2x | XXX | 2.2x | XXX | XXX | XXX |
| P/E | 113.3x | XXX | (152.8x) | XXX | XXX | XXX |
| EV/FCF | 16.3x | XXX | 16.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Enhabit Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Enhabit Margins & Growth Rates
Enhabit's revenue in the last 12 month grew by 4%.
Enhabit's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
Enhabit's rule of 40 is 14% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Enhabit's rule of X is 19% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Enhabit Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 4% | XXX | 4% | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | 10% | XXX | XXX | XXX |
| EBITDA Growth | 2% | XXX | 0% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 14% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 19% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| G&A Expenses to Revenue | 39% | XXX | 41% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 43% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Enhabit Public Comps
See public comps and valuation multiples for other Long-Term Care comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Enhabit | XXX | XXX | XXX | XXX | XXX | XXX |
| Omada Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Propel Funeral Partners | XXX | XXX | XXX | XXX | XXX | XXX |
| LNA Sante | XXX | XXX | XXX | XXX | XXX | XXX |
| Oncology Institute | XXX | XXX | XXX | XXX | XXX | XXX |
| Cross Country Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Enhabit M&A Activity
Enhabit acquired XXX companies to date.
Last acquisition by Enhabit was on XXXXXXXX, XXXXX. Enhabit acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Enhabit
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialEnhabit Investment Activity
Enhabit invested in XXX companies to date.
Enhabit made its latest investment on XXXXXXXX, XXXXX. Enhabit invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Enhabit
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Enhabit
| When was Enhabit founded? | Enhabit was founded in 2014. |
| Where is Enhabit headquartered? | Enhabit is headquartered in United States. |
| How many employees does Enhabit have? | As of today, Enhabit has over 10K employees. |
| Who is the CEO of Enhabit? | Enhabit's CEO is Barbara A. Jacobsmeyer. |
| Is Enhabit publicly listed? | Yes, Enhabit is a public company listed on NYSE. |
| What is the stock symbol of Enhabit? | Enhabit trades under EHAB ticker. |
| When did Enhabit go public? | Enhabit went public in 2022. |
| Who are competitors of Enhabit? | Enhabit main competitors are Omada Health, Propel Funeral Partners, LNA Sante, Oncology Institute. |
| What is the current market cap of Enhabit? | Enhabit's current market cap is $703M. |
| What is the current revenue of Enhabit? | Enhabit's last 12 months revenue is $1B. |
| What is the current revenue growth of Enhabit? | Enhabit revenue growth (NTM/LTM) is 4%. |
| What is the current EV/Revenue multiple of Enhabit? | Current revenue multiple of Enhabit is 1.1x. |
| Is Enhabit profitable? | Yes, Enhabit is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Enhabit? | Enhabit's last 12 months EBITDA is $109M. |
| What is Enhabit's EBITDA margin? | Enhabit's last 12 months EBITDA margin is 10%. |
| What is the current EV/EBITDA multiple of Enhabit? | Current EBITDA multiple of Enhabit is 10.7x. |
| What is the current FCF of Enhabit? | Enhabit's last 12 months FCF is $71M. |
| What is Enhabit's FCF margin? | Enhabit's last 12 months FCF margin is 7%. |
| What is the current EV/FCF multiple of Enhabit? | Current FCF multiple of Enhabit is 16.3x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.